Author: Veronica Silva

Pfizer Canada funds MaRS Innovation for health sciences research

Published on

Pfizer Canada has contributed $800,000 to MaRS Innovation to support new ideas or technologies in health sciences research in areas of therapeutics, diagnostic and treatment tools, and manufacturing technologies. The MaRS Innovation – Pfizer Translational Research Fund will be managed by MaRS Innovation. Priority projects are in cardiovascular disease, inflammation, immunology, rare diseases, vaccines, and…

Read More

Editorial 32-4

Published on

The recently concluded 17th annual RE$EARCH MONEY conference proved to be another success. The feedback we received was overwhelmingly positive, and already there are new ideas about how to make next year’s conference yet another must-attend event for the STI policy and investment community.

It’s not every day that STI stakeholders gather to discuss the pertinent issues of the day. So it was exciting to hear from a wide range of different geographies, sectors and levels of government. Whether it was in the plenary or break-out panel discussions or in networking breaks, discussions were insightful and productive.

Read More

Call for Proposals: Canada-Israel research partnership seeks to fund R&D projects to commercialize

Published on

The Canada-Israel Industrial R&D Foundation (CIIRDF) is accepting proposals for bilateral R&D projects focusing on the commercialization of new technologies. Private sector companies from the two countries are invited to propose joint research, R&D and technology development projects for the creation of innovative products or processes with a non-defence application. The priorities are small- and…

Read More

Aerospace sector gets federal support for innovative helicopters

Published on

An aerospace consortium led by Québec-based Bell Helicopter Textron Canada Ltd. is receiving $49.5 million from the federal government to develop innovative technologies for integration into next-generation helicopters. Support was provided through the Strategic Innovation Fund. With fully autonomous aerial systems, the innovative helicopters will be designed to fly either with or without crew on…

Read More

Zucara Therapeutics secures funding for diabetes drug

Published on

Life sciences firm Zucara Therapeutics Inc. has secured non-dilutive funding of US$3.9 million for the pre-clinical advancement of its lead drug candidate for diabetes, ZT-01. Zucara’s partner, The Leona M. and Harry B. Helmsley Charitable Trust, will provide the funds in the form of a loan under a program-related investment (PRI). ZT-01 is focused on…

Read More

‘Reimagining’ National Academies: A Northern Minerva Reboots

Published on

‘Reimagination’ is very much in the news today (not to be confused with the imagineers at Walt Disney Imagineering R&D subsidiary). We saw the word trotted out in the 2018 federal Budget on how the 101-year-old National Research Council (NRC) was going to form a new conception of itself — not that it hasn’t been reimagined several times before.

Read More

People: Jeff Watts and Pierre Roberge

Published on

Jeff Watts and Pierre Roberge have been appointed president and chief technology officer, respectively, of Prodigy Ventures Inc., a listed innovation company and named by Deloitte as one of Canada’s fastest growing technology companies. Roberge will also serve as senior VP for solutions and ventures. Tom Beckerman remains as company CEO and director. Watts was executive…

Read More

Kraken Robotic pre-qualifies for BCIP

Published on

Kraken Robotic Systems Inc., a wholly owned subsidiary of TSX-listed Kraken Robotics Inc., has pre-qualified to the Build in Canada Innovation Program (BCIP) for the company’s ThunderFish 300 Autonomous Underwater Vehicle (AUV). Under BCIP, Kraken can sell its pre-qualified innovations to the federal government as its first reference sale. The company will receive feedback from…

Read More